ESR1 and breast carcinoma: Notably, changes in cytosolic and membrane ERα is postulated to relate to alterations of the metastatic potential of breast cancer cells, in which prothrombotic cytokines and thrombin83 are released to induce a hypercoagulable state to facilitate tumour progression21,29,68,84.